In addition, it has been found that HDAC inhibitors suppress bone loss in rheumatoid arthritis (RA) as well as in periodontitis and has therefore been suggested as potential treatment models for these diseases [45, 46]. The gene discussed is HDAC9; the disease is rheumatoid arthritis.